Sai Life Sciences IPO allotment: How to check status online on KFin Technologies, BSE, NSE

2 min read | Updated on December 16, 2024, 15:39 IST

SUMMARY

Sai Life Sciences IPO allotment status: Investors who subscribed to Sai Life Sciences IPO can check the allotment status on the official websites of the National Stock Exchange (NSE) and the BSE. The status can also be viewed on the registrar portal Kfin Technologies Ltd.

Sai Life Sciences Limited is a contract research, development, and manufacturing organisation (CRDMO) founded in 1999.

Sai Life Sciences IPO allotment status: Shares of Sai Life Sciences Ltd are expected to be allotted to successful bidders on Monday, December 16, after the IPO received a robust response from institutional investors.

The ₹3,042.62 crore initial share sale was subscribed 10.26 times during the three-day bidding period. It received bids for 39.85 crore shares against 3.88 crore shares on offer.

The qualified institutional buyers (QIBs) attracted 30.93 times subscription, while non-institutional investors (NIIs) mopped up 4.92 times subscription. The retail investors quota was subscribed 1.37 times.

Investors who subscribed to Sai Life Sciences IPO can check the allotment status on the official websites of the National Stock Exchange (NSE) and the BSE. The status can also be viewed on the registrar portal Kfin Technologies Ltd.

Sai Life Sciences IPO allotment date: How to check status online on Kfin Technologies

Go to IPO bid finalisation page of Kfin Technologies - https://evault.kfintech.com/ipostatus/
Choose one server from the five provided and select 'Sai Life Sciences' from the list
Fill in any one of these: PAN, Application number or DP client
Click on submit

Sai Life Sciences IPO allotment: Steps to check status online on NSE website

Go to IPO allotment of NSE by CLICKING HERE.
New users need to sign up and registered users can log in
Enter the details asked, like application number or PAN
Click on the submit button

One can also view Sai Life Sciences IPO allotment status on the BSE website.

Upcoming IPOs: Transrail Lighting along with 3 other IPOs to open for subscription; 12 new listings

Sai Life Sciences IPO listing date

Shares of Sai Life Sciences will be listed on the BSE (formerly Bombay Stock Exchange) and NSE on Wednesday, December 18.

With a price band of ₹522-₹549, the issue consisted of new equity shares worth ₹950 crore and an offer for sale valued at ₹2,092 crore.

The funds generated will be used for debt repayment and general corporate purposes.

Sai Life Sciences IPO: Financials

Particulars	FY22	FY23	FY24	H1FY25
Revenue	₹869.59 cr	₹1,217.1 cr	₹1,465.1 cr	₹675.29 cr
Net Profit	₹6.22 cr	₹9.98 cr	₹82.21 cr	₹28.01 cr

To learn more about IPO listings, schedules, and upcoming IPOs, visit our page.

About The Author

Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Upstox Securities Pvt. Ltd.: SEBI Registration No. INZ000315837 | NSE TM Code: 13942 | BSE TM Code: 6155 | CDSL Reg No.: IN-DP-761-2024 | CIN: U65100DL2021PTC376860 | Compliance Officer: Mr. Kapil Jaikalyani. Tel No.: (022) 24229920. Email ID: compliance@upstox.com | Registered Address: 809, New Delhi House, Barakhamba Road, Connaught Place, New Delhi - 110001 | RKSV Commodities India Pvt. Ltd.: SEBI Registration No.: INZ000015837 | MCX TM Code: 46510 | CIN: U74900DL2009PTC189166 | Compliance Officer: Mr. Amit Lalan. Tel No.: (022) 24229920. Email ID: compliance@rksv.in | Registered Address: 807, New Delhi House, Barakhamba Road, Connaught Place, New Delhi - 110001. Correspondence Address: 30th Floor, Sunshine Tower, Senapati Bapat Marg, Dadar (West), Mumbai - 400013. | For any complaints, email at complaints@upstox.com and complaints.mcx@upstox.com.

Procedure to file a complaint on SEBI SCORES: Register on the SCORES portal. Mandatory details for filing complaints on SCORES include: Name, PAN, Address, Mobile Number, and E-mail ID. Benefits include effective communication and speedy redressal of grievances. Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI, along with our Terms of Use and Privacy Policy.

Upstox Securities Private Limited is a wholly owned subsidiary of RKSV Securities India Private Limited and RKSV Commodities India Private Limited is an associate of RKSV Securities India Private Limited.

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.
*Brokerage will not exceed the SEBI prescribed limit.

Risk disclosures on derivatives -

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Mutual Funds: Top rated funds do not constitute any advice. Research data is powered by Morningstar. Please read the offer documents carefully before investing. Upstox shall not accept any liability arising out of your investments.
These are not Exchange traded products, and the Member is just acting as distributor. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.

Attention Investors: As per NSE circular dated July 6, 2022, BSE circular dated July 6, 2022, MCX circular dated July 11, 2022 investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. Investors are further cautioned to avoid practices like:
a) Sharing i) trading credentials – login id & passwords including OTP’s., ii) trading strategies, iii) position details.
b) Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c) Writing/ selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks
d) Dealing in unsolicited tips through like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e) Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.

Kindly, read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets : Advisory Guidelines For Investors

Kindly, read the advisory as prescribed by the Exchange with reference to their circular dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: KYC Updation

Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from CDSL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Upstox or RKSV and offering such services, please send us an email at complaints@upstox.com and complaints.mcx@upstox.com.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account. Stockbrokers can accept securities as margin from their clients only by way of a pledge in the depository system w.e.f. 1st September 2020.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number to create a pledge.
Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL/CDSL every month.

Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies. https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the-indian-securities-market_74794.html ODR portal for Investors - https://smartodr.in/login

Sai Life Sciences IPO allotment: How to check status online on KFin Technologies, BSE, NSE

Sai Life Sciences IPO allotment date: How to check status online on Kfin Technologies

Sai Life Sciences IPO allotment: Steps to check status online on NSE website

Sai Life Sciences IPO listing date

Sai Life Sciences IPO: Financials

Transrail Lighting IPO: A peer-to-peer analysis of key performance indicators ahead of the IPO

SEBI revises mutual fund rules; introduces new asset class; 'MF Lite' framework for passive funds

ITC sets January 1 as date for hotel business demerger, shares trade in green

Ventive Hospitality, Carraro India, Senores Pharmaceuticals IPOs to open on Dec 20: Key details

Trade setup: Breakout coming for NIFTY50?

NIFTY50 & SENSEX key moves this week?